Formoprl-F 125 Inhaler is a combination medication primarily used to treat and prevent asthma and chronic obstructive pulmonary disease (COPD). Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell and produce extra mucus, leading to difficulty breathing. COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes).

Formoprl-F 125 Inhaler is a combination of two medicines, namely: Formoterol fumarate (bronchodilator) and Fluticasone propionate (corticosteroids). Formoterol fumarate is a long-acting beta-agonist that relaxes the muscles in the airways and increases airflow to the lungs. Thereby making breathing easier by widening the airways. Fluticasone propionate acts by blocking prostaglandin's production (chemical messengers) that cause inflammation (swelling) of the airways. Thereby, it provides relief from sneezing, runny or blocked nose and sinus discomfort. 

Use Formoprl-F 125 Inhaler as advised by the doctor. Your doctor will decide the dose and duration based on your medical condition. The common side effects of Formoprl-F 125 Inhaler include nausea, vomiting, respiratory tract infection, headache, sore throat, cough, bone, muscle or joint pain, increased heart rate, chills, tiredness and noisy breathing. Most of these side effects of Formoprl-F 125 Inhaler do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. 

Do not use Formoprl-F 125 Inhaler to treat sudden severe asthma symptoms or as a rescue inhaler. Please check with your doctor if you are pregnant, currently breastfeeding or taking any other prescribed or non-prescribed medicines. Formoprl-F 125 Inhaler is not recommended for children below five years of age. If you experience severe difficulty in breathing, please consult a doctor immediately so that alternative medicine may be prescribed. Regular monitoring of potassium levels is recommended while taking Formoprl-F 125 Inhaler as it may cause low potassium levels in the blood.

Formoprl-F 125 Inhaler is used to treat and prevent respiratory disorders like asthma and chronic obstructive pulmonary disease (COPD). Formoprl-F 125 Inhaler improves pulmonary function and effectively treats and prevents the worsening of emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of your bronchial tubes). Formoprl-F 125 Inhaler is a combination of Formoterol fumarate and Fluticasone propionate. Formoterol fumarate is a long-acting β₂ agonist and bronchodilator. It relaxes the muscles in the airways and increases airflow to the lungs. It makes breathing easier by widening the airways. Fluticasone propionate belongs to the class of corticosteroids. It acts by blocking prostaglandin's production (chemical messengers) that cause inflammation (swelling) of the airways. Together, Formoprl-F 125 Inhaler helps treat asthma and COPD.

Do not stop taking this medicine of your own unless advised by your doctor. Before taking Formoprl-F 125 Inhaler , let your doctor know if you have a history of heart, liver, kidney diseases, high blood pressure, hypokalaemia (low potassium levels in the blood), aneurysm (swelling of an artery), pheochromocytoma (adrenal gland tumour), hyperadrenocorticism (high levels of cortisol), eye disorders like cataract and glaucoma, chickenpox or measles, immune system problem, seizure (fits), osteoporosis (weak and brittle bones) and diabetes. Formoprl-F 125 Inhaler may cause hypokalemia (low potassium levels in the blood). Therefore they should be used with caution in patients with hypokalaemia to prevent any cardiovascular effects. Special precautions should be taken in patients with a fungal, bacterial, parasitic, or viral infection and tuberculosis since nasal or inhaled corticosteroids like Fluticasone propionate can cause secondary infections. Formoprl-F 125 Inhaler can cause a rise in blood glucose levels. Hence monitor your blood glucose levels regularly and inform your doctor if you already have diabetes before using Formoprl-F 125 Inhaler . Please let your doctor know if you are pregnant or breastfeeding. Formoprl-F 125 Inhaler is not recommended for children below five years of age.

• Take the medication as directed by the doctor and at regular intervals. Do not use other over-the-counter medicines, herbal or vitamin supplements without informing your pharmacist or doctor when you take Formoprl-F 125 Inhaler .
• Know your triggers like allergens, such as pollen, dust and food items that make your asthma severe.
• Quit smoking and avoid passive smoking. Smoking also reduces the effectiveness of the medicine.
• Eat a healthy diet and exercise regularly to strengthen your breathing muscles and boost your immune system.
• Learning breathing exercises will help you move more air in and out of your lungs.

•  
• It is advised to undergo a blood examination to check your potassium levels since Formoprl-F 125 Inhaler can cause low potassium levels in the blood (hypokalaemia).
• Regularly monitor your blood sugar levels while using Formoprl-F 125 Inhaler since bronchodilators like Formoterol fumarate can cause low blood glucose levels.
• Consult your diabetologist if you have diabetes before using Formoprl-F 125 Inhaler so that your insulin or other diabetic medication doses can be adjusted accordingly to maintain your blood sugar levels.
•  

Asthma: It is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. The symptoms of asthma include wheezing (whistling sound while breathing), shortness of breath, chest tightness and cough, especially at night. The treatment for asthma includes medication, breathing exercises and self-care.

Chronic obstructive pulmonary disease (COPD): It is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes). The major cause of COPD is smoking tobacco. Also, long-term exposure to fumes and chemicals may lead to COPD. The symptoms include chronic cough, shortness of breath or wheezing (whistle sound while breathing).